Research into human genetic variation to untangle the complex relationships between genotype and phenotype has provided insight into common and rare diseases, accelerated the pace of drug development, and paved the way for the future of precision medicine. We offer a comprehensive portfolio of genotyping solutions to support all stages of your workflow no matter the number of markers or samples.
In population profiling, moving from discovery to clinical relevance can take years and require multiple technologies and workflows. Our innovative products and expertise enable us to help our customers deliver clinical relevance within an optimal time frame by maximizing actionable insights from samples. Explore our end-to-end solutions from sample collection to analysis.
Pharmacogenomics (PGx)—the study of how genes affect a person’s response to drugs—is an important area of precision medicine because it has the potential to predict an individual’s response to a drug, and can aid in the development of effective and safe medications tailored to an individual’s genetic makeup. Thermo Fisher Scientific offers a variety of solutions to assist you with your PGx research.
Biobanks and biorepositories play an important role in enabling researchers to develop therapies for chronic diseases. Through the collection, storage, inventory, characterization, and distribution of valuable samples from large cohorts of patients, biobanks provide a key tool for research institutions, hospitals, and pharmaceutical and biotechnology companies in their efforts to identify disease biomarkers and provide new treatments.